Roads towards a new tailored therapy for hepatocellular carcinoma: Diagnostic, therapeutic and prognostic implications of microRNAs

Liver International

Volumn 32, Issue 5, 2012, Pages 695-697

  Kim, Chang J ^a   Park, Neung H ^a   Chung, Young Hwa ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1; ALPHA FETOPROTEIN; C19MC MICRORNA; DECARBOXYPROTHROMBIN; INTERFERON; MICRORNA; MICRORNA 16; MICRORNA 26; MICRORNA 26A; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANGIOGENESIS; APOPTOSIS; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER RISK; CANCER SURVIVAL; CELL PROLIFERATION; CHROMOSOME 19; CHRONIC INFLAMMATION; CHRONIC LIVER DISEASE; CPG ISLAND; EDITORIAL; EPIGENETICS; FOOD CONTAMINATION; GENE CLUSTER; GENE EXPRESSION; HEPATITIS; HEPATITIS C; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALIGNANT TRANSFORMATION; NONHUMAN; ONCOGENE; OXIDATIVE STRESS; PATHOGENESIS; RELAPSE; SENSITIVITY AND SPECIFICITY; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

APOPTOSIS; CARCINOMA, HEPATOCELLULAR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE TARGETING; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS; WNT SIGNALING PATHWAY;

EID: 84859388295     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2012.02779.x     Document Type: Editorial

References (17)

1. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007; 45: 507-39.
2. Cha C, Dematteo RP. Molecular mechanisms in hepatocellular carcinoma development. Best Pract Res Clin Gastroenterol 2005; 19: 25-37.
3. Lee JS, Heo J, Libbrecht L, et al. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med 2006; 12: 410-6.
4. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-66.
5. Petri A, Lindow M, Kauppinen S. MicroRNA silencing in primates: towards development of novel therapeutics. Cancer Res 2009; 69: 393-5.
6. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15-20.
7. Chen XM. MicroRNA signatures in liver diseases. World J Gastroenterol 2009; 15: 1665-72.
8. Lu J, Getz G, Miska EA, et al. MiRNA expression profiles classify human cancers. Nature 2005; 435: 834-8.
9. Gao P, Wong CC, Tung EK, et al. Deregulation of microRNA expression occurs early and accumulates in early stages of HBV-associated multistep hepatocarcinogenesis. J Hepatol 2011; 54: 1177-84.
10. Ji J, Shi J, Budhu A, et al. MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med 2009; 361: 1437-47.
11. Xu J, Wu C, Che X, et al. Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Mol Carcinog 2011; 50: 136-42.
12. Qu KZ, Zhang K, Li H, Afdhal NH, Albitar M. Circulating microRNAs as biomarkers for hepatocellular carcinoma. J Clin Gastroenterol 2011; 45: 355-60.
13. Li XD, Li ZG, Song XX, Liu CF. A variant in microRNA-196a2 is associated with susceptibility to hepatocellular carcinoma in Chinese patients with cirrhosis. Pathology 2010; 42: 669-73.
14. Augello C, Vaira V, Caruso L, et al. MicroRNAs profiling of hepatocarcinogenesis identifies C19MC cluster as a novel prognostic biomarker in hepatocellular carcinoma. Liver Int 2012; 32: 772-82.
15. Toffanin S, Hoshida Y, Lachenmayer A, et al. MicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a. Gastroenterology 2011; 140: 1618-28.
16. Lanford RE, Hildebrandt-Eriksen ES, Petri A, et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010; 327: 198-201.
17. Kota J, Chivukula RR, O'Donnell KA, et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009; 137: 1005-17.